In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Medtronic, Genzyme form cardiac repair JV

Executive Summary

Medtronic is forming a joint venture with Genzyme Corp. called MG Biotherapeutics which will be responsible for developing new cardiovascular disease therapeutics.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • R+D and Marketing-Licensing
    • Joint Venture

Related Companies

UsernamePublicRestriction

Register